ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹260 Cr | ₹372 Cr | ₹241 Cr | ₹142 Cr | ₹175 Cr |
What is the latest Total Current Liabilities ratio of ORCHID PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹260 Cr |
Mar2023 | ₹372 Cr |
Mar2022 | ₹241 Cr |
Mar2021 | ₹142 Cr |
Mar2020 | ₹175 Cr |
How is Total Current Liabilities of ORCHID PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹260 Cr | -30.09 | |
Mar2023 | ₹372 Cr | 54.45 | |
Mar2022 | ₹241 Cr | 69.46 | |
Mar2021 | ₹142 Cr | -18.78 | |
Mar2020 | ₹175 Cr | - |
Compare Total Current Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹3,930.8 Cr | 9.9% | -2.5% | -28.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 9.9% |
-2.5% |
-28.7% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses